Judge dismisses lawsuit against Wells Fargo over prescription drug costs
The decision could throw cold water on potential copycat suits seeking to hold large, self-funded employers responsible if they overpay for prescription drugs.
GLP-1s are accelerating spending growth on traditional drugs, Evernorth research finds
Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new report from a Cigna subsidiary.
23andMe files for bankruptcy; CEO Anne Wojcicki resigns
The DNA-testing company plans to sell its assets after the board rejected an acquisition proposal from Wojcicki.
J&J boosts US manufacturing as big pharma reshores
Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.
Medicaid, SNAP cuts could lead to 1 million jobs lost in 2026: report
Reducing spending on Medicaid and the Supplemental Nutrition Assistance Program could batter state economies and lead to job cuts — including 477,000 roles in in the healthcare sector alone next year, according to the Commonwealth Fund.
Yale New Haven Health restructures, consolidates leadership team
The nonprofit provider is cutting up to 38 management and administrative roles.
Delayed CDC meeting on vaccines is rescheduled to April
A panel of CDC advisers, who had been set to meet in February, will discuss the current measles outbreak as well as guidelines for several types of shots.
Balancing innovation and compliance: A risk-smart approach to digital evolution
AI platforms streamline healthcare compliance, automate workflows, and enhance efficiency while ensuring data security.
The future of pharmacy benefits: The shift to insourcing PBM services
The pharmacy benefit landscape is shifting. With rising costs, limited transparency, and rigid structures imposed by legacy pharmacy benefit managers (PBMs), organizations are considering a bold move—bringing their PBM operations in-house.
DEA, HHS delay telehealth buprenorphine prescribing rule again
The final rule, which allows registered clinicians to prescribe up to an initial six-month supply of the drug used to treat opioid use disorder via telehealth, will now go into effect Dec. 31.